Company: PSTV
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0000950170-25-047698
Chunk: 7

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 16
Chunk 7
---
001-34375Exhibit 10.26
    02/24/2022

    10.15#
    Form of Indemnification Agreement
     
    8-K
    001-34375Exhibit 10.1
    02/06/2020

    10.16#
    Form of Agreement for Acceleration and/or Severance
     
    10-K
    001-34375Exhibit 10.113
    03/11/2016

    10.17
    Medidata Services Agreement and Statement of Work, dated November 5, 2021, by and between Medidata Solutions, Inc. and Plus Therapeutics, Inc.  
     
    10-Q
    001-34375Exhibit 10.1
    04/21/2022

    10.18+
    Cancer Research Grant Contract, effective August 31, 2022, by and between the Cancer Prevention and Research Institute of Texas and Plus Therapeutics, Inc. 
     
    8-K
    001-34375Exhibit 10.1
    09/22/2022

    10.19
    Subscription and Investment Representation Agreement, dated March 3, 2023, by and between Plus Therapeutics, Inc. and the purchaser signatory thereto
     
    8-K
    001-34375Exhibit 10.1
    03/03/2023

    10.20#
    Plus Therapeutics, Inc. 2020 Stock Incentive Plan, as further amended and restated
     
    8-K
    001-34375Exhibit 10.1
    04/20/2023

    10.21
    Securities Purchase Agreement, dated as of May 5, 2024, by and among Plus Therapeutics, Inc. and the purchasers named therein 
     
    8-K
    001-34375Exhibit 10.1
    05/09/2024

    10.22
    First Amendment to Securities Purchase Agreement, dated as of May  8, 2024, by and among Plus Therapeutics, Inc. and the purchasers named therein
     
    8-K
    001-34375Exhibit 10.2
    05/09/2024